Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Progenics Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

27 Mar 2015 Reuters Investment Profile 12 $20.00

Trading Report for (PGNX). A detailed report, including free correlated market analysis, and updates.

Detailed Trading Report for PGNX. Entry levels, target prices, and risk controls are integral. In addition, free market anal...

28 Mar 2015 Stock Traders Daily 6 $20.00

Thomson Reuters Stock Report - PROGENICS PHARMACEUTICALS, INC. (PGNX-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Mar 2015 Thomson Reuters Stock Report 12 $25.00

PGNX: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

27 Mar 2015 New Constructs, LLC 9 $25.00

ValuEngine Industry Report for Medical-generic Drugs(PGNX)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

25 Mar 2015 ValuEngine, Inc. 10 $49.00

"The Economy Matters" Report for PGNX: the economy's impact on PGNX's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

23 Mar 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for PGNX

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

23 Mar 2015 ValuEngine, Inc. 11 $25.00

Is Progenics Pharmaceuticals, Inc. Share Price Sustainable?

23 Mar 2015 Sadif Analytics Prime 12 $25.00

Progenics Pharmaceuticals

21 Mar 2015 S&P Capital IQ Quantitative Report 10 $115.00

Value Graph: PROGENICS PHARM -- PGNX

20 Mar 2015 Ford Investor Services, Inc. 1 $12.00